Leaders in Therapeutics Development

Our portfolio companies range from seed-stage startups to publicly traded companies* and are advancing novel therapeutics for patients with a wide range of diseases (oncology, immunology and inflammation, orphan diseases, etc.).

*PORTFOLIO SHOWS ONLY PRIVATE INVESTMENTS – FOR PUBLIC FUND HOLDINGS PLEASE SEE OUR 13F FILINGS.

times icon menu bg caret up